PLASMA APOC-III LEVELS, TRIGLYCERIDES, AND CORONARY ARTERY CALCIFICATION IN TYPE 2 DIABETICS

被引：0
|
作者：
Qamar, Arman [1 ]
Khetarpal, Sumeet [1 ]
Khera, Amit [1 ]
Qasim, Atif [1 ]
Reilly, Muredach [1 ]
Rader, Daniel [1 ]
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2015年 / 65卷 / 10期
关键词：
D O I：
10.1016/S0735-1097(15)61373-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1107-108
引用
收藏
页码：A1373 / A1373
页数：1
相关论文
共 50 条
  • [21] Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease
    Silbernagel, Guenther
    Scharnagl, Hubert
    Kleber, Marcus E.
    Hoffmann, Michael M.
    Delgado, Graciela
    Stojakovic, Tatjana
    Gary, Thomas
    Zeng, Lingyao
    Ritsch, Andreas
    Zewinger, Stephen
    Speer, Thimoteus
    Schunkert, Heribert
    Landmesser, Ulf
    Maerz, Winfried
    Grammer, Tanja B.
    ATHEROSCLEROSIS, 2020, 311 : 84 - 90
  • [22] Plasma turnover of HDL apoC-I, apoC-III and apoE in humans. In vivo evidence for a link between HDL apoC-III and apoA-I metabolism
    Cohn, JS
    Batal, R
    Tremblay, M
    Jacques, H
    Veilleux, L
    Rodriguez, C
    Manner, O
    Davignon, J
    CIRCULATION, 2003, 108 (17) : 197 - 197
  • [23] Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins
    Furtado, Jeremy D.
    Wedel, Mark K.
    Sacks, Frank M.
    JOURNAL OF LIPID RESEARCH, 2012, 53 (04) : 784 - 791
  • [24] Antisense Inhibition of apoB Synthesis with Mipomersen Reduces Plasma apoC-III and apoC-III-Containing Lipoproteins
    Furtado, Jeremy D.
    Tribble, Diane L.
    Wedel, Mark K.
    Sacks, Frank M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : E102 - E102
  • [25] Determinants of progression of coronary artery calcification in type 2 diabetes: The role of plasma osteoprotegerin levels
    Anand, Dhakshinamurthy Vijay
    Corder, Roger
    Darko, Daniel
    Hopkins, David
    Lahiri, Avijit
    CIRCULATION, 2006, 114 (18) : 817 - 817
  • [26] TRANSCRIPTIONAL REGULATION OF THE APOC-III GENE BY INSULIN IN DIABETIC MICE - CORRELATION WITH CHANGES IN PLASMA TRIGLYCERIDE LEVELS
    CHEN, M
    BRESLOW, JL
    LI, WH
    LEFF, T
    JOURNAL OF LIPID RESEARCH, 1994, 35 (11) : 1918 - 1924
  • [27] The relationship between plasma osteoprotegerin levels and coronary artery calcification in uncomplicated type 2 diabetic subjects
    Anand, DV
    Lahiri, A
    Lim, E
    Hopkins, D
    Corder, R
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1850 - 1857
  • [28] Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides
    Prenner, Stuart B.
    Mulvey, Claire K.
    Ferguson, Jane F.
    Rickels, Michael R.
    Bhatt, Anish B.
    Reilly, Muredach P.
    ATHEROSCLEROSIS, 2014, 236 (02) : 244 - 250
  • [29] Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease
    Hopkins, PN
    Wu, LL
    Hunt, SC
    Brinton, EA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (07) : 1003 - 1012
  • [30] Antisense Inhibition of ApoC-III in Rhesus Monkeys Reduces Plasma Triglycerides and Raises HDL-C Without Increasing Hepatic Fat
    Graham, Mark J.
    Kim, Tae-won
    Bell, Thomas A. A.
    Mullick, Adam E.
    Lee, Richard G.
    Fu, Wuxia
    Crooke, Rosanne M.
    CIRCULATION RESEARCH, 2011, 109 (12) : E60 - E60
12345